Farah Jivraj is currently the Head of Market Access and stakeholder relations for Biogen Canada. After receiving her Pharmacy degree and M.Sc. in Health Economics & Health Policy degree from England, Farah worked in South East Asia training Government officials on Health Economics and Policy. Over the last 20 years, Farah has had significant experience in the Health industry, at large Pharmaceutical companies, such as Sanofi Genzyme and Janssen, as well as Biotechnology companies in leadership positions in Medical Affairs, Government & Access and Health Economics. Farah has provided strong leadership and strategic direction on Health Policy and access related functions working with Governments and Private Insurers. She has built relationships with Health Technology Assessment experts to create an optimal Canadian environment to adopt innovative therapies.
Beyond the office, Farah is an active member of her community. She was the Vice Chair for Focus Humanitarian Assistance Canada that helps communities prepare for national and manmade disasters and continues to volunteer in the community. Farah has presented at various leadership conferences on global drug initiatives and cost effectiveness. Farah has one son and resides in the Queen west area of Toronto.
Agenda: Day 1 Oct 6, 2020
Agenda: Day 2 Oct 7, 2020
Panel Discussion: HEALTH ECONOMICS
Integrate Health Economics & Outcome Research in Product Development
Cost-effectiveness analysis is commonly undertaken as a one-off exercise. However, the benefits of an iterative use of economic evaluation during the new product development process have been viewed as extremely valuable. Develop a blueprint to:
- Address complex, systemic health economics and outcomes questions by incorporating big data and system modelling in your approach
- Ensure health economics is covered every step of the way in new product development
Optimize your product development process with big data, system modelling and outcome research.